Navigation Links
Avion Pharmaceuticals, LLC, receives top accolades for trade and marketing achievements at the 11th Annual American Business Awards (The "Stevie Awards")
Date:7/31/2013

ATLANTA, July 31, 2013 /PRNewswire/ -- Avion Pharmaceuticals, a specialty pharmaceutical company, recently announced it received recognitions in several categories at the 2013 American Business Awards, also called "The Stevies," held last month at the Fairmont Hotel in Chicago.  

Avion submitted entries for business excellence and performance in relation to its successful launch of Prenate® Mini prenatal vitamin in 2012.   As a result, the company was recognized for outstanding accomplishments across several categories based on receiving high average scores during more than five weeks of judging.

The Stevie Awards were created in 2002 to honor and generate public recognition of the achievements and positive contributions of organizations and business people worldwide.  Judged each year by more than 200 executives nationwide, the Stevie Awards were designed to raise the profile of exemplary organizations and individuals among the press, the business community, and the general public for their achievements in work life. 

Avion proudly announces the following categories in which it received recognition:

  1. Mark Steffen, Senior Director of Trade and Managed Markets (Bronze Stevie)
    Category: Executive of the Year - Pharmaceuticals
  2. Prenate® Mini Marketing Campaign (Bronze Stevie)
    Category: Marketing Campaign of the Year – Pharmaceuticals
  3. Prenate® Mini Brand Experience (Bronze Stevie)
    Category: Brand Experience of the Year

"Our team at Avion is focused on flawless launch planning and execution.  We work diligently to strategically and tactically develop new products that will benefit both mom and baby and help support our very important Ob/Gyn partner community," stated Mike Sullivan, Vice President, Sales and Marketing, for Avion Pharmaceuticals.        

"Avion Pharmaceuticals is thrilled to be honored with these awards from a very respected and established organization.  To be recognized with a 'Stevie' sets the bar very high and encourages us to continue our focus on innovation and utility in all upcoming launch efforts," added Mark Pugh, CEO.

About Avion Pharmaceuticals, LLC.

Avion Pharmaceuticals, LLC is a Specialty Pharmaceutical company formed to develop and market a portfolio of innovative pharmaceutical products in the Women's Heath and Dermatology therapeutic areas.  Avion Pharmaceuticals focuses on identifying opportunities to acquire and enhance the market potential of innovative, commercially available therapeutics and late-stage development drugs to fulfill unmet medical needs.  For additional information about Avion Pharmaceuticals please contact the company at 678-325-5188 or visit www.avionrx.com.


'/>"/>
SOURCE Avion Pharmaceuticals, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Avion Pharmaceuticals, LLC., announces further expansion of their Womens Health Sales Team
2. Avion Pharmaceuticals, LLC., Launches Prenate Mini
3. Promentis Pharmaceuticals, Inc. Appoints Industry Veteran Chad Beyer, Ph.D., MBA, as President and CEO
4. Imprimis Pharmaceuticals, Inc. Receives Institutional Review Board (IRB) Approval for its Phase III Clinical Trial Protocol; Phase III Clinical Trial to Begin in 3Q 2013
5. ANI Pharmaceuticals, Inc. Announces Date for Second Quarter 2013 Earnings Release
6. Cree, Intuitive Surgical, Alexion Pharmaceuticals, Roche and Onyx Pharmaceuticals highlighted as Zacks Bull and Bear of the Day
7. Vanda Pharmaceuticals, Inc. Sued by Investor
8. Perrigo Company Acquires Ophthalmic Product Portfolio From Fera Pharmaceuticals, LLC For An Upfront Payment Of $93 Million
9. Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc.
10. Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company
11. Imprimis Pharmaceuticals, Inc. to Present at the National Investment Banking Association (NIBA) Conference June 18th in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... June 24, 2016 ... announced the addition of the " Global Markets ... This report focuses ... an updated review, including its applications in various applications. ... market, which includes three main industries: pharmaceutical and biotechnology, ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... ... 24, 2016 , ... Dr. Amanda Cheng, an orthodontist ... has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be used ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
(Date:6/24/2016)... ... 24, 2016 , ... National recruitment firm Slone Partners is pleased ... and genomics experience, as Vice President of North American Capital Sales at HTG ... leading the sales team in the commercialization of the HTG EdgeSeq system and associated ...
Breaking Medicine News(10 mins):